• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    CLOFARABINE IN COMBINATION WITH HIGH-DOSE CYTARABINE AND LIPOSOMAL DAUNORUBICIN IN PEDIATRIC AML: RESULTS OF A PHASE 1 COMBINATION STUDY BY THE ITCC CONSORTIUM 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • CLOFARABINE IN COMBINATION WITH HIGH-DOSE CYTARABINE AND LIPOSOMAL DAUNORUBICIN IN PEDIATRIC AML: RESULTS OF A PHASE 1 COMBINATION STUDY BY THE ITCC CONSORTIUM
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • CLOFARABINE IN COMBINATION WITH HIGH-DOSE CYTARABINE AND LIPOSOMAL DAUNORUBICIN IN PEDIATRIC AML: RESULTS OF A PHASE 1 COMBINATION STUDY BY THE ITCC CONSORTIUM
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    CLOFARABINE IN COMBINATION WITH HIGH-DOSE CYTARABINE AND LIPOSOMAL DAUNORUBICIN IN PEDIATRIC AML: RESULTS OF A PHASE 1 COMBINATION STUDY BY THE ITCC CONSORTIUM

    View/Open
    Submitted version (15.60Kb)
    Volume
    61
    Pagination
    S138 - S138
    ISSN
    1545-5009
    Metadata
    Show full item record
    Authors
    Zwaan, CM; Dworzak, M; Klingebiel, T; Roessig, C; Leverger, G; Stary, J; de Bont, ES; Niemeyer, CM; Kaspers, GJ; Bertrand, Y
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/10799
    Collections
    • Centre for Haemato-Oncology [167]
    Copyright statements
    2014. American Society of Hematology
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.